🇺🇸 FDA
Patent

US 10562930

Salts and crystal forms of GABAA positive allosteric modulator

granted A61KA61K31/4164A61K9/20

Quick answer

US patent 10562930 (Salts and crystal forms of GABAA positive allosteric modulator) held by PRAXIS PRECISION MEDICINES, INC. expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRAXIS PRECISION MEDICINES, INC.
Grant date
Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4164, A61K9/20, A61K9/2004, A61P